Cost-Effectiveness of Nirsevimab and Maternal RSVpreF Vaccination Strategies in Low-Risk Infants

Recommended citation: Sean Tsung*, Yan Bo Zeng*, Kevan Shah, Steven Asch, Joshua A. Salomon, Douglas K. Owens, and Kevin Chen. (2026). "Cost-Effectiveness of Nirsevimab and Maternal RSVpreF Vaccination Strategies in Low-Risk Infants." Pediatrics.
Download Paper